Atomi Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$409K Buy
12,067
+649
+6% +$21.6K 0.01% 868
2026
Q1
$344K Buy
11,418
+1,075
+10% +$34.6K 0.01% 882
2025
Q4
$323K Buy
+10,343
New +$255K 0.01% 896

Other funds holding TEVA

Atomi Financial Group's TEVA Position: Q2 2026 in Review

Atomi Financial Group increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 5.7% in Q2 2026, buying an estimated $21.6K and bringing the position to 12,067 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #868.

Atomi Financial Group first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Atomi Financial Group held 12,067 shares of Teva Pharmaceutical Industries Limited worth $409K as of Q2 2026.
  • Atomi Financial Group bought 649 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $21.6K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #868 holding.
  • Atomi Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q4 2025 and has held it in 3 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.